| Evan K Tummel, MD | |
|
515 S Kings Ave Ste 1100, Brandon, FL 33511-6060 | |
| (813) 530-4944 | |
| (813) 530-4495 |
| Full Name | Evan K Tummel |
|---|---|
| Gender | Male |
| Speciality | General Surgery |
| Experience | 18 Years |
| Location | 515 S Kings Ave Ste 1100, Brandon, Florida |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1689846024 | NPI | - | NPPES |
| 014367100 | Medicaid | FL |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208600000X | Surgery | ME107238 (Florida) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| St Josephs Hospital | Tampa, FL | Hospital |
| St Anthonys Hospital | Saint petersburg, FL | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Womens Care Florida Llc | 9234031444 | 293 |
News Archive
Caliper Life Sciences, Inc., a leading provider of tools and services for drug discovery and life sciences research, today announced the formation of a scientific advisory board to guide its efforts in automated sample preparation for next generation and third generation sequencing platforms. Caliper worked closely with leading genome centers to develop the LabChip® XT, which was announced today, and is now expanding its efforts to develop additional solutions for next generation sequencing workflows.
An alliance of brain researchers and funders has announced a common data format to facilitate the free and open exchange of complex information about the brain-information that scientists can then use to accelerate progress in understanding the brain and developing new treatments for brain disorders.
By giving ordinary adult mice a drug - a synthetic designed to mimic fat - Salk Institute scientist Dr. Ronald M. Evans is now able to chemically switch on PPAR-d, the master regulator that controls the ability of cells to burn fat.
Alnylam Pharmaceuticals, Inc., a leading RNAi therapeutics company, announced today it has formed a collaboration with GlaxoSmithKline (GSK) focused on Alnylam's VaxiRNATM technology for certain GSK vaccine products, including influenza. VaxiRNA is a new RNAi technology for the enhanced production of viruses used in the manufacture of vaccine products. GSK, a leading vaccine manufacturer, is the first company to form a collaboration accessing this new platform.
› Verified 9 days ago
| Entity Name | Womens Care Florida Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1013902923 PECOS PAC ID: 9234031444 Enrollment ID: O20040127000078 |
News Archive
Caliper Life Sciences, Inc., a leading provider of tools and services for drug discovery and life sciences research, today announced the formation of a scientific advisory board to guide its efforts in automated sample preparation for next generation and third generation sequencing platforms. Caliper worked closely with leading genome centers to develop the LabChip® XT, which was announced today, and is now expanding its efforts to develop additional solutions for next generation sequencing workflows.
An alliance of brain researchers and funders has announced a common data format to facilitate the free and open exchange of complex information about the brain-information that scientists can then use to accelerate progress in understanding the brain and developing new treatments for brain disorders.
By giving ordinary adult mice a drug - a synthetic designed to mimic fat - Salk Institute scientist Dr. Ronald M. Evans is now able to chemically switch on PPAR-d, the master regulator that controls the ability of cells to burn fat.
Alnylam Pharmaceuticals, Inc., a leading RNAi therapeutics company, announced today it has formed a collaboration with GlaxoSmithKline (GSK) focused on Alnylam's VaxiRNATM technology for certain GSK vaccine products, including influenza. VaxiRNA is a new RNAi technology for the enhanced production of viruses used in the manufacture of vaccine products. GSK, a leading vaccine manufacturer, is the first company to form a collaboration accessing this new platform.
› Verified 9 days ago
| Entity Name | Knd Development 59 Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1245569870 PECOS PAC ID: 3678602802 Enrollment ID: O20100908000056 |
News Archive
Caliper Life Sciences, Inc., a leading provider of tools and services for drug discovery and life sciences research, today announced the formation of a scientific advisory board to guide its efforts in automated sample preparation for next generation and third generation sequencing platforms. Caliper worked closely with leading genome centers to develop the LabChip® XT, which was announced today, and is now expanding its efforts to develop additional solutions for next generation sequencing workflows.
An alliance of brain researchers and funders has announced a common data format to facilitate the free and open exchange of complex information about the brain-information that scientists can then use to accelerate progress in understanding the brain and developing new treatments for brain disorders.
By giving ordinary adult mice a drug - a synthetic designed to mimic fat - Salk Institute scientist Dr. Ronald M. Evans is now able to chemically switch on PPAR-d, the master regulator that controls the ability of cells to burn fat.
Alnylam Pharmaceuticals, Inc., a leading RNAi therapeutics company, announced today it has formed a collaboration with GlaxoSmithKline (GSK) focused on Alnylam's VaxiRNATM technology for certain GSK vaccine products, including influenza. VaxiRNA is a new RNAi technology for the enhanced production of viruses used in the manufacture of vaccine products. GSK, a leading vaccine manufacturer, is the first company to form a collaboration accessing this new platform.
› Verified 9 days ago
| Entity Name | Womens' Health Hospitalists, Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1205295599 PECOS PAC ID: 1850674870 Enrollment ID: O20170216001354 |
News Archive
Caliper Life Sciences, Inc., a leading provider of tools and services for drug discovery and life sciences research, today announced the formation of a scientific advisory board to guide its efforts in automated sample preparation for next generation and third generation sequencing platforms. Caliper worked closely with leading genome centers to develop the LabChip® XT, which was announced today, and is now expanding its efforts to develop additional solutions for next generation sequencing workflows.
An alliance of brain researchers and funders has announced a common data format to facilitate the free and open exchange of complex information about the brain-information that scientists can then use to accelerate progress in understanding the brain and developing new treatments for brain disorders.
By giving ordinary adult mice a drug - a synthetic designed to mimic fat - Salk Institute scientist Dr. Ronald M. Evans is now able to chemically switch on PPAR-d, the master regulator that controls the ability of cells to burn fat.
Alnylam Pharmaceuticals, Inc., a leading RNAi therapeutics company, announced today it has formed a collaboration with GlaxoSmithKline (GSK) focused on Alnylam's VaxiRNATM technology for certain GSK vaccine products, including influenza. VaxiRNA is a new RNAi technology for the enhanced production of viruses used in the manufacture of vaccine products. GSK, a leading vaccine manufacturer, is the first company to form a collaboration accessing this new platform.
› Verified 9 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Evan K Tummel, MD Po Box 748817, Atlanta, GA 30374-8817 Ph: (813) 286-0033 | Evan K Tummel, MD 515 S Kings Ave Ste 1100, Brandon, FL 33511-6060 Ph: (813) 530-4944 |
News Archive
Caliper Life Sciences, Inc., a leading provider of tools and services for drug discovery and life sciences research, today announced the formation of a scientific advisory board to guide its efforts in automated sample preparation for next generation and third generation sequencing platforms. Caliper worked closely with leading genome centers to develop the LabChip® XT, which was announced today, and is now expanding its efforts to develop additional solutions for next generation sequencing workflows.
An alliance of brain researchers and funders has announced a common data format to facilitate the free and open exchange of complex information about the brain-information that scientists can then use to accelerate progress in understanding the brain and developing new treatments for brain disorders.
By giving ordinary adult mice a drug - a synthetic designed to mimic fat - Salk Institute scientist Dr. Ronald M. Evans is now able to chemically switch on PPAR-d, the master regulator that controls the ability of cells to burn fat.
Alnylam Pharmaceuticals, Inc., a leading RNAi therapeutics company, announced today it has formed a collaboration with GlaxoSmithKline (GSK) focused on Alnylam's VaxiRNATM technology for certain GSK vaccine products, including influenza. VaxiRNA is a new RNAi technology for the enhanced production of viruses used in the manufacture of vaccine products. GSK, a leading vaccine manufacturer, is the first company to form a collaboration accessing this new platform.
› Verified 9 days ago
John Kimble Butterick, M.D. Surgery Medicare: Not Enrolled in Medicare Practice Location: 302 Bryan Rd, Suite 2, Brandon, FL 33511 Phone: 813-681-7512 Fax: 813-684-8974 | |
In Soon Park, MD Surgery Medicare: Accepting Medicare Assignments Practice Location: 519 Medical Oaks Ave, Brandon, FL 33511 Phone: 813-685-7995 Fax: 813-685-8802 | |
Dr. Darshan B Thakkar, MD Surgery Medicare: Accepting Medicare Assignments Practice Location: 116 Parsons Park Dr, Brandon, FL 33511 Phone: 813-684-5255 | |
Subhasis Misra, MD Surgery Medicare: Accepting Medicare Assignments Practice Location: 205 S Moon Ave Ste 102a, Brandon, FL 33511 Phone: 813-662-6200 Fax: 813-571-1688 | |
Dr. Jeffrey Scott Mino, M.D. Surgery Medicare: Accepting Medicare Assignments Practice Location: 519 Medical Oaks Ave, Brandon, FL 33511 Phone: 813-685-7995 Fax: 813-685-8802 | |
Dr. Samer Koussayer, MD Surgery Medicare: Accepting Medicare Assignments Practice Location: 325 South Parsons Ave, Brandon, FL 33511 Phone: 813-681-4644 Fax: 813-654-4486 | |
Dr. Charles James Bailey, M.D. Surgery Medicare: Accepting Medicare Assignments Practice Location: 270 S Moon Ave, Brandon, FL 33511 Phone: 813-571-9988 Fax: 813-571-9922 |